U.S. healthcare gets plenty of bang for its buck out of community health workers (CHWs), according to a systematic review of the relevant published research.
No group fared particularly well in an analysis from Trilliant Health looking at publicly reported data. Most of the new utilization of mental health services was for anxiety, with women seeking care most often.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
When preparing for life as both doctors and parents, new mothers and mothers-to-be suffer significantly less burnout if they’re supported by targeted, well-planned support.
Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.
Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care.
Artificial intelligence's role in day-to-day patient care continues to grow. What should health systems and cardiology departments be thinking about as they shop for new technologies?
"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.
U.S. healthcare gets plenty of bang for its buck out of community health workers (CHWs), according to a systematic review of the relevant published research.
No group fared particularly well in an analysis from Trilliant Health looking at publicly reported data. Most of the new utilization of mental health services was for anxiety, with women seeking care most often.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
